The LDL-C/ApoB ratio predicts major cardiovascular events in patients with established atherosclerotic cardiovascular disease

Autor: Arthur Mader, Heinz Drexel, Berthold Moser, Alexander Vonbank, Daniela Zanolin-Purin, Barbara Larcher, Christoph H. Saely, Christine Heinzle
Rok vydání: 2021
Předmět:
Zdroj: Atherosclerosis. 329:44-49
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2021.05.010
Popis: Background and aims The low density lipoprotein cholesterol to Apolipoprotein B (LDL-C/ApoB) ratio is a validated proxy for low density lipoprotein (LDL) particle size that can be easily calculated from a standard lipid/apolipoprotein profile. Whether it is predictive of cardiovascular events in patients with established atherosclerosis is not known and is addressed in the present investigation. Methods We determined the LDL-C/ApoB ratio in a cohort of 1687 subjects with established atherosclerosis. Prospectively, major cardiovascular events (MACE) including cardiovascular death, non-fatal myocardial infarction and non-fatal stroke were recorded over a period of 9.9 ± 4.6 years. The study covers >16,000 patient-years. Results At baseline, the LDL-C/ApoB ratio was 1.36 ± 0.28 in our cohort. During follow up, a total of 558 first MACE were recorded. The LDL-C/ApoB ratio predicted MACE in univariate Cox proportional hazard analysis (HR 0.90 [0.82–0.98]; p = 0.014); this finding was confirmed after adjustment for age, gender, intensity of statin treatment, hypertension, history of smoking, type 2 diabetes, body mass index and ApoB (HR 0.87 [0.78–0.97]; p = 0.013). Conclusions The LDL-C/ApoB ratio is independently predictive of MACE in subjects with established atherosclerosis.
Databáze: OpenAIRE